Powerful Gene Editing Approach Offers the Promise of Correcting a Range of Rare Diseases

David Liu, director of the Merkin Institute for Transformative Technologies at the Broad Institute, discussing a recent study of base editing to treat the rare disease progeria, how it works, and why it may offer the potential to treat a wide range of rare diseases.